Back To TopGet Opthea Updates
Ian Leitch

Ian Leitch

Ian Leitch has been Director of Clinical Research of Opthea since September 2011. He has over 20 years of research and management experience from drug discovery through clinical development in biotechnology/pharmaceutical companies. For the five years prior to joining...
Sarika Gulhar 

Sarika Gulhar 

Sarika Gulhar is Opthea’s Executive Director of Human Resources since January 2023. With over 30 years of HR management experience, Sarika is a seasoned HR executive known for enhancing corporate culture and building high-performance teams in companies across...
Mike Gerometta

Mike Gerometta

Mike Gerometta has been Head of Chemistry, Manufacturing & Controls (CMC) Development for Opthea since 2008 with responsibilities encompassing outsourcing of Opthea’s biopharmaceutical research and cGMP manufacturing activities for its therapeutic and diagnostic...
Mark O’Neill

Mark O’Neill

Mark O’Neill was appointed Vice President CMC in January 2022.  Mr. O’Neill was most recently head of Process Development for Avexis Gene therapies where he orchestrated all product development and technical operations activities pertaining to the startup and...
Karen Adams

Karen Adams

Karen Adams was appointed Vice President Finance in May 2021 and Company Secretary in June 2021. Karen is accountable directly to the board, through the chair, on all matters to do with the proper functioning of Opthea’s board. Prior to joining Opthea, Karen was the...
Bruno Gagnon

Bruno Gagnon

Bruno joined Opthea in July 2022 and leads Global Clinical Operations. Bruno is former Sr. Vice President of Development Operations at Eidos Therapeutics, a BridgeBio company in San Francisco, CA. He also served as Vice President of Clinical Operations at BioMarin...